menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial

11 0
30.01.2026
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.

© Fortune